Introduction

Japanese encephalitis is a mosquito-borne viral disease that can cause severe neurological damage or even death. In Hong Kong and across Asia, the risk is significant and should not be overlooked. Fortunately, the live-attenuated Japanese encephalitis chimeric vaccine (JE-CV) offers effective prevention. This article draws from recent studies and health authority guidelines to explain the benefits, vaccination schedule, and local transmission status of JE-CV.

What is Japanese Encephalitis?

Japanese encephalitis virus is primarily transmitted by Culex mosquitoes, particularly Culex tritaeniorhynchus. It is prevalent in Asia and the Western Pacific, where infections may be asymptomatic but severe cases can lead to encephalitis, paralysis, or death. According to the World Health Organization (WHO), there are tens of thousands of cases globally each year.

In Hong Kong, local cases are rare, but residents near pig farms face a 20-fold higher risk. The Centre for Health Protection estimates that up to 633,000 people are affected, mainly in the New Territories West. Prevention focuses on avoiding mosquito bites and vaccination.

Benefits of the JE-CV Vaccine

JE-CV is a live-attenuated chimeric vaccine approved by Hong Kong’s Department of Health in 2014. It is suitable for children from 9 months and adults, providing long-term protection.

Key Research Evidence:

• A randomized controlled Phase III trial in the Philippines involved 450 children aged 36-42 months. Results showed strong immune responses from JE-CV boosters in previously vaccinated children.
• An open-label crossover study in Thailand with 100 children aged 2-5 (previously vaccinated with mouse-brain vaccine) and 200 toddlers aged 12-24 months demonstrated JE-CV’s safety and immunogenicity.
• A trial with 1,200 children aged 12-18 months in Thailand and the Philippines confirmed excellent protection with no serious side effects.

These studies highlight JE-CV’s safety and efficacy in children, with lasting immune memory.

Vaccination Schedule

For Children Aged 9 Months to 17 Years:

• Primary Dose: Single subcutaneous injection.
• Booster: 12-24 months after primary dose.

For Adults Aged 18 and Above:

• Primary Dose: Single injection.
• Booster: As needed, 12-24 months apart.

Vaccination should be administered by healthcare professionals, following Hong Kong’s Reference Framework for Preventive Care for Children.

Transmission Risks and Prevention in Hong Kong

Based on the Food and Environmental Hygiene Department’s 2004-2005 survey, Culex tritaeniorhynchus is widely distributed in Hong Kong. The Centre for Health Protection’s 2017 consensus statement recommends:

• Priority vaccination for residents within 2 km of pig farms.
• Enhanced environmental monitoring, such as eliminating standing water to reduce mosquito breeding.
• Use of insect repellents (e.g., DEET) and wearing long-sleeved clothing.

Prevention Tips:

• Avoid outdoor activities at dusk and dawn.
• Exercise caution near pig farms or rural areas.

Conclusion

The JE-CV vaccine is a powerful tool against Japanese encephalitis, ideal for Hong Kong residents and travelers. Consult your doctor to assess personal risks and get vaccinated promptly. Health starts with prevention—let’s protect our loved ones together.

References: Based on Centre for Health Protection, WHO, and relevant clinical trials. See official guidelines for details.